• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

CHL Medical Partners

edit

CHL Medical Partners is a premier venture capital firm dedicated to partnering with entrepreneurs and inventors to create and finance innovative biotechnology, molecular diagnostic, healthcare service and medical device companies. Our team is well-known among industry observers and healthcare investment professionals for identifying and validating visionary scientific ideas and healthcare service models and then creating businesses with extraordinary market potential around these breakthrough concepts. Collectively, we have invested in and grown more than 80 start-ups, establishing a notable track record of building prominent companies with products and services that significantly improve patient care. We are currently investing from our sixth fund, the $120 million CHL Medical Partners III, L.P.

Recent Milestones

edit

• 
  CHL Medical Partners invested in DICOM Grid. (5/16/12)
  Posted 5/16/12 at 7:17pm via dowjones.com
• 
  CHL Medical Partners invested in OpGen. (3/7/12)
  Posted 3/12/12 at 6:15pm via finsmes.com
• 
  CHL Medical Partners invested in Mevion Medical Systems. (1/24/12)
  Posted 1/24/12 at 7:51pm via mevion.com
• 
  CHL Medical Partners invested in Valeritas. (9/12/11)
  Posted 9/12/11 at 5:48pm via finsmes.com
• 
  CHL Medical Partners invested in DICOM Grid. (11/4/10)
  Posted 11/4/10 at 7:12pm via finsmes.com
• 
  CHL Medical Partners invested in Vascular Pathways. (11/1/10)
  Posted 11/1/10 at 9:52pm via finsmes.com
• 
  CHL Medical Partners invested in OpGen. (9/28/10)
  Posted 9/27/10 at 9:41pm via opgen.com
• 
  CHL Medical Partners invested in Vertos Medical. (1/17/10)
  Posted 1/19/10 at 11:41pm via onbiovc.com
• 
  CHL Medical Partners invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm via onbiovc.com
• 
  CHL Medical Partners invested in VaxInnate. (6/14/09)
  Posted 6/16/09 at 8:28am via onbiovc.com
• 
  CHL Medical Partners invested in Still River Systems. (1/1/09)
  Posted 4/14/09 at 6:16am via bio-medicine.org
• 
  CHL Medical Partners invested in POINT Biomedical. (1/1/08)
  Posted 6/17/09 at 6:49pm
• 
  CHL Medical Partners invested in OpGen. (9/12/07)
  Posted 3/12/10 at 3:50am via opgen.com
• 
  CHL Medical Partners invested in BioRelix. (6/11/07)
  Posted 3/22/12 at 6:18pm via masshightech.com
• 
  CHL Medical Partners invested in VaxInnate. (10/25/06)
  Posted 4/20/10 at 3:21am via thefreelibrary.com

Investments

Videos

Sources

1. Dicom Grid Raises $5M Expansion Round From Canaan, CHL Medical (pevc.dowjones.com) [edit]
2. OpGen to Receive up to $17M in Financing (finsmes.com) [edit]
3. Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems (mevion.com) [edit]
4. Valeritas Raises $150m in Series C financing. (finsmes.com) [edit]
5. DICOM Grid Secures $7.5M in Series A Financing (finsmes.com) [edit]
6. Vascular Pathways Closes $14M Series B Financing (finsmes.com) [edit]
7. OpGen Completes $17 Million Series B Financing (opgen.com) [edit]
8. Vertos Medical, Inc.: Series D $15.5M (onbiovc.com) [edit]
9. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
10. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]
11. Still River Systems, Inc. Secures $33 Million in Private Financing (bio-medicine.org) [edit]
12. Capital Funding Report [edit]
13. OpGen Announces $23.6 Million Series A Financing (opgen.com) [edit]
14. Nutmeg State biotech lands $25.8M in round one (masshightech.com) [edit]
15. VaxInnate Secures $40 Million Series C Financing. (thefreelibrary.com) [edit]